Michael Dee, MD
Orthopaedic Surgery · Layton, UTNPI 1710106653
Payments from drug & device makers
Across 87 payments — averaging $33.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Active Medical, LLC$721
- Stryker$462
- Smith+Nephew$229
- Pacira Pharmaceuticals Incorporated$189
- Johnson & Johnson$168
- Zimmer Biomet$158
- plus $985 from 32 others
What the payments were for
- Travel & lodging$29010%
- Food & beverage$1,97668%
- Education$64622%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Active Medical, LLC | 3 | $721 |
| Stryker | 9 | $462 |
| Smith+Nephew | 7 | $229 |
| Pacira Pharmaceuticals Incorporated | 5 | $189 |
| Johnson & Johnson | 7 | $168 |
| Zimmer Biomet | 5 | $158 |
| Vericel Corporation | 6 | $129 |
| Anika Therapeutics, Inc. | 4 | $111 |
| Solventum Corporation | 3 | $74 |
| Boehringer Ingelheim | 3 | $56 |
| Nevro Corp. | 2 | $53 |
| Vertex | 2 | $42 |
| Amgen | 2 | $35 |
| Corcept Therapeutics | 2 | $31 |
| AbbVie | 1 | $30 |
| Lilly USA, LLC | 2 | $28 |
| Moximed, Inc | 1 | $27 |
| Bioventus LLC | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $25 |
| Alafair Biosciences, Inc. | 1 | $24 |
| Endo Pharmaceuticals Inc. | 1 | $24 |
| Globus Medical | 1 | $22 |
| International Rehabilitative Sciences, Inc | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Nalu Medical, Inc. | 1 | $19 |
| Seqirus USA Inc | 1 | $17 |
| Exact Sciences | 1 | $17 |
| Shield Therapeutics Inc | 1 | $16 |
| Si-bone, Inc. | 1 | $16 |
| Davol Inc. | 1 | $15 |
| Orthofix Medical, Inc. | 1 | $14 |
| Pfizer | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Medtronic | 1 | $14 |
| AstraZeneca | 1 | $13 |
| Dynavax Technologies Corporation | 1 | $13 |
| Abbott | 1 | $12 |
| Genentech USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SALVATION$290
How this compares
$2,912 in reported general payments places this provider in the 40th percentile of 221 orthopaedic surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 154 | $2,146 |
| Ondansetron Hcl | 48 | $267 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 41 | $240 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $127 |
| Methocarbamol | 12 | $107 |
| Cefadroxil | 11 | $67 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Layton
- Tyler KentLayton$25K
- Hugh WestMurray$14.2M
- Aaron HofmannSalt Lake City$10.7M
- Armen KhachatryanWest Jordan$3.9M
- Thomas CaltonWashington Terrace$3.5M
- Jeremy GilillandSalt Lake City$3.3M
- Robert TashjianSalt Lake City$3M
- Joshua HickmanBountiful$2.7M
- Jeffrey JacksonSalt Lake City$2.3M
- Peter StevensSlc$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.